NEXGEL, Inc. ( NXGL) - Key Metrics
NXGL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.41 | -$0.40 | -$0.24 | -$0.25 |
| 2026Q1 | $0.32 | -$0.11 | -$0.06 | -$0.06 |
| 2025Q4 | $0.36 | -$0.12 | $0.04 | $0.04 |
| 2025Q3 | $0.37 | -$0.08 | -$0.10 | -$0.10 |
| 2025Q2 | $0.38 | -$0.09 | -$0.05 | -$0.06 |
NXGL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.31 |
| 2026Q1 | 0% | -1.44 |
| 2025Q4 | 0% | -3.35 |
| 2025Q3 | 0% | -7.63 |
| 2025Q2 | 0% | -7.42 |
NXGL
Price: $0.29
52 week price:
Earnings Per Share: -0.74 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 3300
Market Capitalization: 2.9 million